1. In a retrospective case series study, researchers investigated ophthalmic complications associated with antidiabetic drugs, semaglutide and tirzepatide.
2. Nine patients developed vision-related complications while using these medications.
3. Researchers hypothesized a potential association between rapid glycemic control induced by these medications and observed ophthalmic events.
4. The American Academy of Ophthalmology recommended that patients who experience vision loss while taking semaglutide should stop the drug and contact their prescribing physician.
5. A postmarketing surveillance study might better inform physicians and patients about the safety of semaglutide.

Source: JAMA Ophthalmology